These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22455493)

  • 21. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M; Wilschut J; de Haan A
    Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple.
    Polack FP
    Pediatr Res; 2007 Jul; 62(1):111-5. PubMed ID: 17515829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the development of subunit-based RSV vaccines.
    Jaberolansar N; Toth I; Young PR; Skwarczynski M
    Expert Rev Vaccines; 2016; 15(1):53-68. PubMed ID: 26506139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive and therapeutic strategies for respiratory syncytial virus infection.
    Vujovic O; Mills J
    Curr Opin Pharmacol; 2001 Oct; 1(5):497-503. PubMed ID: 11764776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
    Huang Y; Cyr SL; Burt DS; Anderson R
    J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of truncated G protein delivered by live attenuated Salmonella as a vaccine against respiratory syncytial virus.
    Tian P; Xu D; Huang Z; Meng F; Fu J; Wei H; Chen T
    Microb Pathog; 2018 Feb; 115():299-303. PubMed ID: 29306006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
    Valosky J; Hishiki H; Zaoutis TE; Coffin SE
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization strategies for the prevention of pneumovirus infections.
    Bennett N; Ellis J; Bonville C; Rosenberg H; Domachowske J
    Expert Rev Vaccines; 2007 Apr; 6(2):169-82. PubMed ID: 17408367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?
    Hussell T; Openshaw P
    Curr Opin Microbiol; 1999 Aug; 2(4):410-4. PubMed ID: 10458984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in respiratory syncytial virus vaccine development.
    Kneyber MC; Kimpen JL
    Curr Opin Investig Drugs; 2004 Feb; 5(2):163-70. PubMed ID: 15043390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.
    Welliver TP; Reed JL; Welliver RC
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S92-6. PubMed ID: 18820587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.
    Jorquera PA; Anderson L; Tripp RA
    Expert Rev Vaccines; 2016; 15(2):173-87. PubMed ID: 26641318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
    Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
    Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.
    González PA; Bueno SM; Riedel CA; Kalergis AM
    Curr Med Chem; 2009; 16(34):4609-25. PubMed ID: 19903147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory syncytial virus infection in adults.
    Falsey AR
    Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of a neonatal mouse model to study respiratory syncytial virus infections.
    Cormier SA; You D; Honnegowda S
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1371-80. PubMed ID: 21133663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.
    Ascough S; Paterson S; Chiu C
    Front Immunol; 2018; 9():323. PubMed ID: 29552008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RSV--a substantial slice of the airway disease burden and the way to a vaccine.
    Weigl JA
    Paediatr Int Child Health; 2012 Nov; 32 Suppl 2():S9-15. PubMed ID: 23394753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.